LASA SUPERGENERICS
Back to Balance Sheet
|
LASA SUPERGENERICS Last 5 Year Total Liabilities History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹151 Cr | ₹164 Cr | ₹209 Cr | ₹208 Cr | ₹229 Cr |
What is the latest Total Liabilities ratio of LASA SUPERGENERICS ?
| Year | Total Liabilities |
|---|---|
| Mar2024 | ₹151 Cr |
| Mar2023 | ₹164 Cr |
| Mar2022 | ₹209 Cr |
| Mar2021 | ₹208 Cr |
| Mar2020 | ₹229 Cr |
How is Total Liabilities of LASA SUPERGENERICS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | ₹151 Cr | -7.93 | |
| Mar2023 | ₹164 Cr | -21.66 | |
| Mar2022 | ₹209 Cr | 0.63 | |
| Mar2021 | ₹208 Cr | -9.16 | |
| Mar2020 | ₹229 Cr | - | |
Compare Total Liabilities of peers of LASA SUPERGENERICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LASA SUPERGENERICS | ₹39.7 Cr | -7.9% | -15.7% | -66.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,753.0 Cr | 1.5% | 5.5% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,032.0 Cr | 2.3% | 3.6% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,426.0 Cr | -0.5% | 5.3% | 40.2% | Stock Analytics | |
| CIPLA | ₹108,360.0 Cr | -1.1% | -2.2% | -8.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,859.0 Cr | 0.9% | 5.2% | 7% | Stock Analytics | |
LASA SUPERGENERICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LASA SUPERGENERICS | -7.9% |
-15.7% |
-66.4% |
| SENSEX | 0.2% |
1.1% |
8.8% |
You may also like the below Video Courses